-+ 0.00%
-+ 0.00%
-+ 0.00%

Coya Therapeutics Reports Positive Results from FTD Study of Low-Dose IL-2 and CTLA4-Ig Combination Therapy

Reuters·01/08/2026 13:01:32

Please log in to view news